rss Posted March 24, 2022 Report Share Posted March 24, 2022 Int J Dermatol. 2022 Mar 24. doi: 10.1111/ijd.16160. Online ahead of print. ABSTRACT Tranexamic acid is a plasmin inhibitor that is used off-label for the treatment of melasma. The use of tranexamic acid has expanded in the field of dermatology based on its anti-inflammatory and anti-melanin-producing properties, which include the treatment of rosacea, urticaria, and post-inflammatory hyperpigmentation. Tranexamic acid may have more uses in dermatology that require future studies. It should be used with caution during the COVID-19 pandemic given its procoagulant nature. PMID:35323992 | DOI:10.1111/ijd.16160 {url} = URL to article RRDi Members Only Link to comment Share on other sites More sharing options...
Recommended Posts
Create an account or sign in to comment
You need to be a member in order to leave a comment
Create an account
Sign up for a new account in our community. It's easy!
Register a new accountSign in
Already have an account? Sign in here.
Sign In Now